Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral treosulfan in advanced pre-treated Ewing's sarcoma
ISRCTN11631773Phase 2Completed
- Sponsor
- University College London
- Start
- Feb 2010
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of treosulfan in Ewing sarcoma of bone, sponsored by University College London. Primary endpoint: Objective response rate. Started Feb 2010; status: completed.
02
Drugs
treosulfan
03
Conditions
Ewing sarcoma of bone
Beyond the preview
Go deeper on ISRCTN11631773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN11631773.